Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 10, 2018; 90 (15 Supplement) April 26, 2018

A bout of confusion: Atypical presentations of Anti-Leucine-rich-Glioma-Inactivated 1(LGI-1) encephalitis – an emerging cause of limbic encephalitis (LE) (P5.393)

Karan Topiwala, Anvi Patel, Neil Datta, Yan Zhang, Isaac Silverman
First published April 9, 2018,
Karan Topiwala
1University of Connecticut, Hartford Hospital Hartford CT United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anvi Patel
1University of Connecticut, Hartford Hospital Hartford CT United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil Datta
1University of Connecticut, Hartford Hospital Hartford CT United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yan Zhang
2Hartford Hospital Hartford CT United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isaac Silverman
2Hartford Hospital Hartford CT United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
A bout of confusion: Atypical presentations of Anti-Leucine-rich-Glioma-Inactivated 1(LGI-1) encephalitis – an emerging cause of limbic encephalitis (LE) (P5.393)
Karan Topiwala, Anvi Patel, Neil Datta, Yan Zhang, Isaac Silverman
Neurology Apr 2018, 90 (15 Supplement) P5.393;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective:

  1. Underscore increasing recognition of LGI-1 encephalitis as a cause of LE

  2. Report two cases of Anti-LGI-1 encephalitis that presented without the pathognomonic Fascio-Brachial Dystonic Seizures (FBDS)

  3. Consider modified diagnostic criteria for anti-LGI-1 Encephalitis.

Background: LGI-1 is a trans-synaptic modulator protein that was first identified in 2010 as a target in anti-VGKC autoimmune encephalitis. Anti-LGI-1 encephalitis is now the most common cause of LE (subacute behavioural disturbance, memory loss and focal seizures) amongst the anti-neuronal-cell-surface antibody encephalitides. The relative occurrence of four clinical/laboratory features that are most sensitive for Anti-LGI-1 encephalitis include [1]presenting-as-LE(90%) [2]Bi-temporal-T2-hyperintensities(74%) [3]hyponatremia(65%) [4]normal CSF study(75%). Alhough FBDS is a pathognomonic feature of Anti-LGI encephalitits it is only seen in upto 40% cases.

Design/Methods: Case Report

Results: We report 2 cases of CSF-antibody positive Anti-LGI-LE without the pathognomonic FBDS. First was was a 35-year-old-woman who presented with 3 weeks of confusion, memory loss and auditory hallucinations, found to have bi-temporal-T2-hyperintensities and a normal EEG study. The second was a 79-year-old-man with 2 weeks of confusion and memory loss who developed a generalised tonic clonic seizure, found to have multiple brief right temporal focal seizures on EEG with an unremarkable MRI brain. Their work up showed normal serum, CSF studies except for mild hyponatremia and were suspected to have Anti-LGI1 encephalitis based on the presence of 3 out of the above 4 features with subsequently positive Anti-LGI1 antibodies detected in the CSF of both patients.

Conclusions: Majority of patients with Anti-LGI1 encephalitis will not develop FBDS as noted in our cases. We propose that presence of 3 out of the above 4 features makes anti-LGI-1 encephalitits a likley diagnosis even in the absence of FBDS. Further studies are required to evaluate the sensitivity and specificty of these modified criteria.

Disclosure: Dr. Topiwala has nothing to disclose. Dr. Patel has nothing to disclose. Dr Datta has nothing to disclose. Dr. Zhang has nothing to disclose. Dr. Silverman has nothing to disclose.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 96 (9)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise